178 related articles for article (PubMed ID: 24915510)
1. The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households.
Finkelstein EA; Chay J; Bajpai S
PLoS One; 2014; 9(6):e99572. PubMed ID: 24915510
[TBL] [Abstract][Full Text] [Related]
2. The macroeconomic burden of noncommunicable diseases associated with air pollution in China.
Chen S; Bloom DE
PLoS One; 2019; 14(4):e0215663. PubMed ID: 30998763
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19.
Odunyemi A; Rahman T; Alam K
BMC Public Health; 2023 Aug; 23(1):1563. PubMed ID: 37592334
[TBL] [Abstract][Full Text] [Related]
4. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
[TBL] [Abstract][Full Text] [Related]
5. The global impact of non-communicable diseases on households and impoverishment: a systematic review.
Jaspers L; Colpani V; Chaker L; van der Lee SJ; Muka T; Imo D; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
Eur J Epidemiol; 2015 Mar; 30(3):163-88. PubMed ID: 25527371
[TBL] [Abstract][Full Text] [Related]
6. Is Health Insurance Associated with Health Service Utilization and Economic Burden of Non-Communicable Diseases on Households in Vietnam?
Giang NH; Oanh TTM; Anh Tuan K; Hong Van P; Jayasuriya R
Health Syst Reform; 2020; 6(1):1-15. PubMed ID: 31592715
[TBL] [Abstract][Full Text] [Related]
7. Assessing the relationship between out-of-pocket spending on blood pressure and diabetes medication and household catastrophic health expenditure: evidence from Pakistan.
Datta BK; Husain MJ; Asma S
Int J Equity Health; 2019 Jan; 18(1):9. PubMed ID: 30646905
[TBL] [Abstract][Full Text] [Related]
8. Households' Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia.
Almalki ZS; Alahmari AK; Alqahtani N; Alzarea AI; Alshehri AM; Alruwaybiah AM; Alanazi BA; Alqahtani AM; Ahmed NJ
Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955092
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Cardiovascular Diseases in the Elderly Population in Indonesia: Evidence from Population-Based Indonesian Family Life Survey (IFLS).
Zakaria SI; Alfian SD; Zakiyah N
Vasc Health Risk Manag; 2022; 18():905-914. PubMed ID: 36605931
[TBL] [Abstract][Full Text] [Related]
10. Economic costs of diabetes in the US in 2002.
Hogan P; Dall T; Nikolov P;
Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
[TBL] [Abstract][Full Text] [Related]
11. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of diabetes in Brazil in 2014.
Bahia LR; da Rosa MQM; Araujo DV; Correia MG; Dos Rosa RDS; Duncan BB; Toscano CM
Diabetol Metab Syndr; 2019; 11():54. PubMed ID: 31303899
[TBL] [Abstract][Full Text] [Related]
13. Multimorbidity, healthcare use and catastrophic health expenditure by households in India: a cross-section analysis of self-reported morbidity from national sample survey data 2017-18.
Karan A; Farooqui HH; Hussain S; Hussain MA; Selvaraj S; Mathur MR
BMC Health Serv Res; 2022 Sep; 22(1):1151. PubMed ID: 36096819
[TBL] [Abstract][Full Text] [Related]
14. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
15. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
16. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
[TBL] [Abstract][Full Text] [Related]
17. Healthcare utilisation and expenditure patterns for cardio-metabolic diseases in South Asian cities: the CARRS Study.
Gupta P; Singh K; Shivashankar R; Singh K; Vamadevan A; Mohan V; Kadir MM; Tandon N; Narayan KM; Prabhakaran D; Ali MK
BMJ Open; 2020 Sep; 10(9):e036317. PubMed ID: 32998917
[TBL] [Abstract][Full Text] [Related]
18. The household-level economic burden of heart disease in India.
Karan A; Engelgau M; Mahal A
Trop Med Int Health; 2014 May; 19(5):581-91. PubMed ID: 24612174
[TBL] [Abstract][Full Text] [Related]
19. Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh.
Rahman T; Gasbarro D; Alam K
BMC Public Health; 2022 Sep; 22(1):1835. PubMed ID: 36175951
[TBL] [Abstract][Full Text] [Related]
20. The projected economic burden of non-communicable diseases attributable to overweight in Brazil by 2030.
Giannichi B; Nilson E; Ferrari G; Rezende LFM
Public Health; 2024 May; 230():216-222. PubMed ID: 38579649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
